Assessing an Oral Janus Kinase Inhibitor, AZD4205, in Combination With Osimertinib in Patients Who Have Advanced Non-small Cell Lung Cancer
about
Assessing an Oral Janus Kinase Inhibitor, AZD4205, in Combination With Osimertinib in Patients Who Have Advanced Non-small Cell Lung Cancer
description
clinical trial
@en
klinisch onderzoek
@nl
name
Assessing an Oral Janus Kinase ...... ced Non-small Cell Lung Cancer
@en
type
label
Assessing an Oral Janus Kinase ...... ced Non-small Cell Lung Cancer
@en
prefLabel
Assessing an Oral Janus Kinase ...... ced Non-small Cell Lung Cancer
@en
P1476
A Phase I/II, Open-Label, Mult ...... Small Cell Lung Cancer (NSCLC)
@en
P17
P1813
JACKPOT1
@en
P3098
NCT03450330
P4844
P580
2018-04-16T00:00:00Z
P582
2020-07-01T00:00:00Z